ALOX5 and Alzheimer disease: The dual inhibition of COX-2 and 5-LOX thus represents a promising strategy to address the interplay between inflammation and the cholinergic system, potentially alleviating cognitive symptoms and slowing the progression of neurodegeneration in AD.